Fluidigm Corp. | Mutual Funds
Mutual Funds that own Fluidigm Corp.
PRIMECAP Odyssey Aggressive Growth Fund
3,866,032
9.86%
16,000
0.27%
06/30/2018
Vanguard Investment Series Plc - US Opportunities Fund
1,926,011
4.92%
900
0.48%
06/30/2018
Neuberger Berman Intrinsic Value Fund
1,443,659
3.69%
-105,000
1.42%
06/30/2018
Transamerica Large Cap Value Fund
1,275,129
3.26%
113,903
0.44%
01/31/2018
Worldwide Healthcare Trust Plc
837,999
2.14%
-176
0.32%
09/30/2017
Vanguard Total Stock Market Index Fund
798,097
2.04%
105,369
0%
07/31/2018
iShares Russell 2000 ETF
699,699
1.79%
-375
0.01%
09/06/2018
Vanguard Extended Market Index Fund
429,183
1.1%
0
0.01%
07/31/2018
Biotech Growth Trust Plc (The)
344,463
0.88%
-125
0.39%
09/30/2017
Russell Focused US Equity Pool
261,913
0.67%
109,018
0.57%
12/31/2017
| Address |
7000 Shoreline Court
South San Francisco California 94080
United States
|
|
Employees
|
- |
| Website |
http://www.fluidigm.com |
| Updated |
07/08/2019 |
| Fluidigm Corp. engages in the manufacture and marketing of innovative technologies and tools for life sciences research. It sells instruments and consumables, including integrated fluidic circuits; assays and reagents to academic institutions; clinical research laboratories, and biopharmaceutical; agricultural biotechnology; and companies and contract research organizations. The company was founded by Stephen R. |
